|
|
News Breaks
|
| 06:17 EDT |  | BAYRY |
| theflyonthewall.com: | Bayer appeal rejected by Indian court, Times of India reports | | The Delhi high court has reportedly dismissed an appeal by German MNC Bayer (BAYRY), which was looking to link regulatory approval of generic medicines with their patent status. The judgment was made on an anti-cancer drug, as patent linkage is against public health interests. Reference Link :theflyonthewall.com |
|
|
News For BAYRY From The Last 14 Days Check below for free stories on BAYRY the last two weeks.
There are 7 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
September 7, 2010
|
| 16:09 EDT |  | BAYRY |
|
|
September 1, 2010
|
| 09:09 EDT |  | BAYRY |
| theflyonthewall.com: | Leerink's biotech analysts holds an analyst/industry conference call | | Biotech Analyst Schimmer, along with a clinical investigator in trials for Biogen Idec and Bayer, Dr. Jerry Powell, discuss long acting factor replacements for Hemophilia. Relevant companies include BAX, BAYRY, BIIB, CSL, NVO and PFE on the Analyst/Industry conference call to be held on September 2 at 1 pm hosted by Leerink. :theflyonthewall.com |
|
|
August 31, 2010
|
| 13:45 EDT | | BAYRY |
| | 12:20 EDT |  | BAYRY |
| | 07:35 EDT | | BAYRY |
|
|
August 30, 2010
|
| 08:12 EDT | | BAYRY |
|
|
August 26, 2010
|
| 10:42 EDT | | BAYRY |
| theflyonthewall.com: | Leerink's biotech analyst holds an analyst/industry conference call | | Biotech Analyst Fernandez discusses expectations that BMY/PFE's Apixaban will have a strong position in the $10-$20B warfarin replacement market and discusses the potential risks and opportunities for primary competitors JNJ/BAYRY's Xarelto and Boehringer Ingelheim's Pradaxa on an Analyst/Industry conference call being held on August 27 at 11 am hosted by Leerink. :theflyonthewall.com |
|
|
|
|
|
Subscribe for More Information